Sponsor

Inotek Pharmaceuticals Corporation

Clinical research sponsor

Published trials4

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

4 shown

Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAGNCT02829996 · lead sponsor · 2016-08-19

COMPLETED

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle GlaucomaNCT02565173 · lead sponsor · 2015-09-01

COMPLETED

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaNCT01917383 · lead sponsor · 2013-08-01

COMPLETED

A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaNCT01123785 · lead sponsor · 2010-05-01

COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.